ISO 19015:2025
(Main)Traditional Chinese medicine — Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and seedlings
Traditional Chinese medicine — Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and seedlings
This document specifies the requirements and test methods of Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and seedlings. This document is applicable to Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and Glycyrrhiza uralensis seedlings that are sold for the production of Glycyrrhiza uralensis and Glycyrrhiza glabra root as natural medicines in international trade including Chinese materia medica (whole medicinal materials) and decoction pieces.
Médecine traditionnelle chinoise — Graines et plants de Glycyrrhiza uralensis et de Glycyrrhiza glabra
General Information
- Status
- Published
- Publication Date
- 05-Jun-2025
- Technical Committee
- ISO/TC 249 - Traditional Chinese medicine
- Drafting Committee
- ISO/TC 249 - Traditional Chinese medicine
- Current Stage
- 6060 - International Standard published
- Start Date
- 06-Jun-2025
- Due Date
- 20-Jan-2026
- Completion Date
- 06-Jun-2025
Overview
ISO 19015:2025 sets out international requirements and test methods for Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and seedlings, supporting the quality and safety of these foundational materials in traditional Chinese medicine (TCM). As medicinal plants with a long history and global use, G. uralensis (Chinese licorice) and G. glabra (common licorice) play a crucial role in pharmacopoeias and herbal preparations worldwide. The standard addresses the growing need for reliable seed and seedling quality to ensure effective, safe, and consistent raw materials for medicine production and international trade.
This standard is applicable to seeds and seedlings sold for the production of licorice roots used in traditional medicines and herbal decoction pieces. It provides detailed requirements for product quality, grading, sampling, laboratory testing, packaging, storage, and labeling, ensuring international harmonization and facilitating global trade in TCM materials.
Key Topics
Seed and Seedling Quality Requirements
- Minimum quality standards for seeds (purity, viability, maturity, moisture, germination percentage, seed mass)
- Grading system (first, second, third grade) for seeds and seedlings based on physical and biological characteristics
Sampling and Testing
- Methods for representative seed and seedling sampling
- Laboratory tests for purity, viability, germination, moisture content, nematode detection, and morphological parameters
- Reference to ISTA (International Seed Testing Association) methodologies
Packaging, Storage, and Labeling
- Guidance on suitable packaging to maintain seed and seedling integrity
- Storage conditions to prolong viability and prevent contamination
- Required labeling and product marking for traceability and compliance
International Trade Compliance
- Harmonization of test methods and grading with global best practices
- Requirements aligned with pharmacopoeial and regulatory standards in major markets
Applications
Pharmaceutical and Herbal Industries
This standard is essential for seed producers, nurseries, herbal medicine manufacturers, and exporters/importers engaged in the international trade of Glycyrrhiza uralensis and Glycyrrhiza glabra. It helps:
- Ensure consistent quality of raw medicinal materials entering the supply chain
- Comply with pharmacopoeia requirements across major regions (China, Europe, Japan, Korea, United States)
- Support product registration and regulatory submissions in diverse markets
Cultivation and Plantation Management
Nurseries and agricultural producers benefit from ISO 19015:2025 by:
- Selecting high-quality seeds and seedlings that maximize yield and efficacy of the final medicinal product
- Reducing risks associated with diseases, pests, and inferior plant material
- Enhancing traceability and quality assurance from the very beginning of the value chain
International Trade and Compliance
Exporters and importers use this standard to:
- Meet buyer and regulatory expectations for documented quality control
- Streamline customs clearance and reduce disputes over material quality
- Access broader markets with standardized documentation and testing certificates
Related Standards
- ISO 21371: Traditional Chinese medicine - Labelling requirements of products intended for oral or topical use
- ISO 22217: Traditional Chinese medicine - Storage requirements for raw materials and decoction pieces
- ISTA International Rules for Seed Testing: Reference for seed testing methodologies
- ISO/TR 23975: Priority list of single herbal medicines for developing standards
- ISO 17217-1: Related seed and seedling requirements for Panax ginseng (for reference in test methods and terminology)
- Pharmacopoeias: Chinese, European, Japanese, Korean, and United States Pharmacopoeia
ISO 19015:2025 serves the global medicinal plant supply chain by standardizing the quality assurance process for Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and seedlings, contributing to the safety, effectiveness, and sustainability of traditional Chinese medicine and related industries.
Get Certified
Connect with accredited certification bodies for this standard

BSI Group
BSI (British Standards Institution) is the business standards company that helps organizations make excellence a habit.

TÜV Rheinland
TÜV Rheinland is a leading international provider of technical services.

TÜV SÜD
TÜV SÜD is a trusted partner of choice for safety, security and sustainability solutions.
Sponsored listings
Frequently Asked Questions
ISO 19015:2025 is a standard published by the International Organization for Standardization (ISO). Its full title is "Traditional Chinese medicine — Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and seedlings". This standard covers: This document specifies the requirements and test methods of Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and seedlings. This document is applicable to Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and Glycyrrhiza uralensis seedlings that are sold for the production of Glycyrrhiza uralensis and Glycyrrhiza glabra root as natural medicines in international trade including Chinese materia medica (whole medicinal materials) and decoction pieces.
This document specifies the requirements and test methods of Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and seedlings. This document is applicable to Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and Glycyrrhiza uralensis seedlings that are sold for the production of Glycyrrhiza uralensis and Glycyrrhiza glabra root as natural medicines in international trade including Chinese materia medica (whole medicinal materials) and decoction pieces.
ISO 19015:2025 is classified under the following ICS (International Classification for Standards) categories: 11.120.10 - Medicaments. The ICS classification helps identify the subject area and facilitates finding related standards.
ISO 19015:2025 is available in PDF format for immediate download after purchase. The document can be added to your cart and obtained through the secure checkout process. Digital delivery ensures instant access to the complete standard document.
Standards Content (Sample)
International
Standard
ISO 19015
First edition
Traditional Chinese medicine —
2025-06
Glycyrrhiza uralensis and
Glycyrrhiza glabra seeds and
seedlings
Médecine traditionnelle chinoise — Graines et plants de
Glycyrrhiza uralensis et de Glycyrrhiza glabra
Reference number
© ISO 2025
All rights reserved. Unless otherwise specified, or required in the context of its implementation, no part of this publication may
be reproduced or utilized otherwise in any form or by any means, electronic or mechanical, including photocopying, or posting on
the internet or an intranet, without prior written permission. Permission can be requested from either ISO at the address below
or ISO’s member body in the country of the requester.
ISO copyright office
CP 401 • Ch. de Blandonnet 8
CH-1214 Vernier, Geneva
Phone: +41 22 749 01 11
Email: copyright@iso.org
Website: www.iso.org
Published in Switzerland
ii
Contents Page
Foreword .iv
Introduction .v
1 Scope . 1
2 Normative references . 1
3 Terms and definitions . 1
4 Descriptions . 3
5 Requirements and recommendations . 6
5.1 General characteristics .6
5.2 Glycyrrhiza uralensis and Glycyrrhiza glabra seeds .6
5.3 Glycyrrhiza uralensis seedlings.7
6 Sampling . 7
6.1 Seed sampling . .7
6.2 Seedling sampling .8
7 Test methods . 8
7.1 External test .8
7.2 Purity .8
7.3 Maturity .8
7.4 Seed viability .8
7.5 Germination percentage .8
7.6 Seed moisture content .8
7.7 1 000-seed mass .9
7.8 Nematode testing .9
7.9 Seedling mass .9
7.10 Hibernaculum diameter .9
7.11 Root length .9
8 Test report . 9
9 Packaging, storage and transportation . 9
10 Marking . .10
Bibliography .11
iii
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out through
ISO technical committees. Each member body interested in a subject for which a technical committee
has been established has the right to be represented on that committee. International organizations,
governmental and non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely
with the International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
The procedures used to develop this document and those intended for its further maintenance are described
in the ISO/IEC Directives, Part 1. In particular, the different approval criteria needed for the different types
of ISO document should be noted. This document was drafted in accordance with the editorial rules of the
ISO/IEC Directives, Part 2 (see www.iso.org/directives).
ISO draws attention to the possibility that the implementation of this document may involve the use of (a)
patent(s). ISO takes no position concerning the evidence, validity or applicability of any claimed patent
rights in respect thereof. As of the date of publication of this document, ISO had not received notice of (a)
patent(s) which may be required to implement this document. However, implementers are cautioned that
this may not represent the latest information, which may be obtained from the patent database available at
www.iso.org/patents. ISO shall not be held responsible for identifying any or all such patent rights.
Any trade name used in this document is information given for the convenience of users and does not
constitute an endorsement.
For an explanation of the voluntary nature of standards, the meaning of ISO specific terms and expressions
related to conformity assessment, as well as information about ISO's adherence to the World Trade
Organization (WTO) principles in the Technical Barriers to Trade (TBT), see www.iso.org/iso/foreword.html.
This document was prepared by Technical Committee ISO/TC 249, Traditional medicine, Subcommittee SC 1,
Traditional Chinese medicine.
Any feedback or questions on this document should be directed to the user’s national standards body. A
complete listing of these bodies can be found at www.iso.org/members.html.
iv
Introduction
Liquorice is one of the most frequently used medicinal plants and has been used as a traditional Chinese
medicine (TCM) for more than 4 000 years. It is widely used in medicine, food and cosmetics industry
worldwide. It is rich in triterpenoids and flavonoids, such as ammonium glycyrrhizinate, glycyrrhizin,
liquiritin, liquiritigenin, isoliquiritigenin, isoliquiritin, glabridin, and has antitumor, antimicrobial, antiviral,
antiinflammatory, immunoregulatory, antioxidant and other effects. It is included in the Pharmacopoeia of
the People's Republic of China, European Pharmacopoeia, Japanese Pharmacopoeia, Korean Pharmacopoeia
and United States Pharmacopoeia. It is also used as a sweetener, an antioxidant, an antibacterial agent, a
foaming agent and a flavour enhancer. Meanwhile, it is a food additive approved by the European Union,
the United States, China and other countries (or regions). Glabridin is recognized as a safe whitening agent
because it has a significant inhibitory effect on tyrosinase activity and has low toxicity to melanocytes.
Between 2019 and 2021, a total of 119 countries (or regions) engaged in international trade of liquorice
products. 3 countries (or regions) only exported and 60 countries (or regions) only imported liquorice
products. 56 countries (or regions) both exported and imported liquorice products. It is ranked no. 1 in the
priority list of single herbal medicines for developing standards in ISO/TR 23975.
Three original plants, Glycyrrhiza uralensis Fisch., Glycyrrhiza glabra L. and Glycyrrhiza inflata Bat. are
defined as liquorice in the Pharmacopoeia of the People’s Republic of China, European Pharmacopoeia and
Korean Pharmacopoeia. Due to high-intensity anthropogenic activities that cause habitat destruction and
uncontrolled exploitation, liquorice resources have become increasingly limited. With the development of
artificial cultivation technology geared towards meeting the growing market demands, cultivated varieties
of liquorice have become the primary source of liquorice products. At present, only G. uralensis and G. glabra
have realized the large-scale cultivation. High quality seeds and seedlings are the assurance of the efficacy
and safety of clinical drug use. In the production of G. uralensis and G. glabra, the problems of confusion,
heterozygosity and uneven quality of seeds and seedlings often occur. At present, an international
standard for G. uralensis and G. glabra seeds and seedlings is absent. Therefore, it is urgent to formulate
an international standard for G. uralensis and G. glabra seeds and seedlings. It is the requirement of the
global trade and production. It can ensure the higher productivity and better product quality from origin
and benefit seed or seedling trading, plantation and the related pharmaceutical industry.
v
International Standard ISO 19015:2025(en)
Traditional Chinese medicine — Glycyrrhiza uralensis and
Glycyrrhiza glabra seeds and seedlings
1 Scope
This document specifies the requirements and test methods of Glycyrrhiza uralensis and Glycyrrhiza glabra
seeds and seedlings.
This document is applicable to Glycyrrhiza uralensis and Glycyrrhiza glabra seeds and Glycyrrhiza uralensis
seedlings that are sold for the production of Glycyrrhiza uralensis and Glycyrrhiza glabra root as natural
medicines in international trade including Chinese materia medica (whole medicinal materials) and
decoction pieces.
2 Normative references
The following documents are referred to in the text in such a way that some or all of their content constitutes
requirements of this document. For dated references, only the edition cited applies. For undated references,
the latest edition of the referenced document (including any amendments) applies.
ISO 21371, Traditional Chinese medicine — Labelling requirements of products intended for oral or topical use
ISO 22217, Traditional Chinese medicine —Storage requirements for raw materials and decoction pieces
International Seed Testing Association (ISTA), International Rules for Seed Testing
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
ISO and IEC maintain terminology databases for use in standardization at the following addresses:
— ISO Online browsing platform: available at https:// www .iso .org/ obp
— IEC Electropedia: available at https:// www .electropedia .org/
3.1
seed lot
specified quantity of the seed (3.7) that is physically and u
...




Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.
Loading comments...